Keap1 Cancer Research Results
Keap1, Kelch-like ECH-associated protein 1: Click to Expand ⟱
| Source: |
| Type: |
Kelch-like ECH-associated protein 1 (Keap1) is a key regulator of the transcription factor Nrf2.
-In several tumor types, loss of Keap1 function (either due to gene mutations or low protein expression) results in unrestrained Nrf2 activity.
• Persistent Nrf2 activation is thought to:
- Provide tumor cells with enhanced protection against oxidative stress.
- Contribute to chemoresistance and radioresistance.
- Promote metabolic reprogramming that fuels tumor growth.
• Thus, in many cancers, altered Keap1 status can serve as an indicator of poor prognosis and has been investigated as a potential target for therapeutic intervention.
|
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
PSA, |
NA |
|
|
|
BioAv↝, *memory↑, *ROS↓, *AChE↓, *NF-kB↓, *Keap1↝, *NRF2↑, *Inflam↓, *PGC-1α↝, *HO-1↓, *p‑tau↓, *cognitive↑, *BDNF↑, *5HT↑, *Stroke↓, *PARP1↓, *AIF↓, *Casp3↓, NP/CIPN↓, *neuroP↑, *NGF↑, *TNF-α↓, *IL1β↓, *IL18↓, *IL6↓, *VCAM-1↓, *pol-M2 MC↑, *hepatoP↑, *AST↓, *ALAT↓, *LC3II↑, *Beclin-1/ATG6↑, *p62↑, *COX2/PTGS2↑, *MMP↑, *ATP↑, *GSH↑, *Catalase↑, *GPx↑, *MDA↓, *antiPs↑, *AntiDiabetic↑, *glucose↓, *Insulin↑, *GutMicro↑, *Obesity↓, COX2/PTGS2↓, cycD1/CCND1↓, TumCCA↑, EGFR↓, GSK‐3β↑, Mcl-1↓, *toxicity↓, TumCP↓, Hif1a↓, VEGF↓, ERK↓, LAMs↓, Cyt‑c↑, Casp9↑, Casp3↑, PARP↑, TumCD↑, mitA↑, BACH1↓, P53↓, ROS↑, PD-1↓, NF-kB↓, *Bacteria↓, *AntiViral↑, *mt-ROS?, *PI3K↓, *chemoP↑, ChemoSen↑, Synergy↑, *toxicity↓, *BioAv↑, *BioAv↑, *Synergy↑, *antiAll↑,
*hepatoP↑, *ROS↓, *PGC-1α↝, *NRF2↑, *HO-1↑, *NQO1↝, *Keap1↝, *GCLC↝, *GCLM↝, *NLRP3↓, *IL1β↓, *IL6↓, *TNF-α↓, *MIP2↓, *Bax:Bcl2↓, *cl‑Casp3↓, *Inflam↓, *Apoptosis↓,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
GSK‐3β↑, 1,
Cell Death(tgid=5) ⓘ
Casp3↑, 1, Casp9↑, 1, Cyt‑c↑, 1, Mcl-1↓, 1, TumCD↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
EGFR↓, 1, ERK↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↓, 1, PARP↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
cycD1/CCND1↓, 1, mitA↑, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
TumCP↓, 1,
Migration(tgid=13) ⓘ
BACH1↓, 1, LAMs↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
Hif1a↓, 1, VEGF↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↓, 1, NF-kB↓, 1, PD-1↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↝, 1, ChemoSen↑, 1, Synergy↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
EGFR↓, 1,
Functional Outcomes(tgid=23) ⓘ
NP/CIPN↓, 1,
Total Targets: 27
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
Catalase↑, 1, GCLC↝, 1, GCLM↝, 1, GPx↑, 1, GSH↑, 1, HO-1↓, 1, HO-1↑, 1, Keap1↝, 2, MDA↓, 1, NQO1↝, 1, NRF2↑, 2, ROS↓, 2, mt-ROS?, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
Insulin↑, 1, PGC-1α↝, 2,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ALAT↓, 1, ATP↑, 1, glucose↓, 1,
Cell Death(tgid=5) ⓘ
AIF↓, 1, Apoptosis↓, 1, Bax:Bcl2↓, 1, Casp3↓, 1, cl‑Casp3↓, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
PI3K↓, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
Beclin-1/ATG6↑, 1, LC3II↑, 1, p62↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
PARP1↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
VCAM-1↓, 1,
Barriers & Transport(tgid=15) ⓘ
MMP↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↑, 1, IL18↓, 1, IL1β↓, 2, IL6↓, 2, Inflam↓, 2, pol-M2 MC↑, 1, MIP2↓, 1, NF-kB↓, 1, NLRP3↓, 1, TNF-α↓, 2,
Synaptic & Neurotransmission(tgid=18) ⓘ
5HT↑, 1, AChE↓, 1, BDNF↑, 1, NGF↑, 1,
Protein Aggregation(tgid=19) ⓘ
p‑tau↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 2, Synergy↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 1, AST↓, 1, IL6↓, 2,
Functional Outcomes(tgid=23) ⓘ
antiAll↑, 1, AntiDiabetic↑, 1, antiPs↑, 1, chemoP↑, 1, cognitive↑, 1, hepatoP↑, 2, memory↑, 1, neuroP↑, 1, Obesity↓, 1, Stroke↓, 1, toxicity↓, 2,
Infection & Microbiome(tgid=24) ⓘ
AntiViral↑, 1, Bacteria↓, 1, GutMicro↑, 1,
Total Targets: 64
Scientific Paper Hit Count for: Keap1, Kelch-like ECH-associated protein 1
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:1 prod#:% Target#:1174 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid
Home Page